Document is current
Any future updates will be listed below
-
Authors
Al-Qiam, Reema A.
Dumbare, Sachin
Graf, Tyler N.
Vidar, Warren S.
Raja, Huzefa A.
Pearce, Cedric J.
Hematian, Shabnam
Oberlies, Nicholas H.
-
Funding
Funding for this research was provided by:
National Cancer Institute (P01 CA125066, P01 CA125066)
University of North Carolina
U.S. Department of Energy (DE-SC0024433)
- License Information
-
More Information
Article History
Received: 19 June 2025
Accepted: 10 September 2025
First Online: 3 October 2025
Declarations
:
: Not applicable.
: Not applicable.
: NHO and CJP have ownership interests in Ionic Pharmaceuticals. HAR, TNG, CJP and NHO are members of the Scientific Advisory Board of Clue Genetics, Inc. NHO is also a member of the Scientific Advisory Board of Mycosynthetix, Inc.
